Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa.
about
Epidemiology of human African trypanosomiasisA targeted door-to-door strategy for sleeping sickness detection in low-prevalence settings in Côte d’IvoirePredicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of CongoPerformance of parasitological and molecular techniques for the diagnosis and surveillance of gambiense sleeping sicknessIntroducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasisPerformance of the SD BIOLINE® HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the CongoAPOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis.Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.Unravelling human trypanotolerance: IL8 is associated with infection control whereas IL10 and TNFα are associated with subsequent disease developmentHuman african trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review.Epidemiology of sleeping sickness in Boffa (Guinea): where are the trypanosomes?Progress towards the eradication of Tsetse from the Loos islands, Guinea.The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambienseAccuracy of individual rapid tests for serodiagnosis of gambiense sleeping sickness in West Africa.Identification of sVSG117 as an immunodiagnostic antigen and evaluation of a dual-antigen lateral flow test for the diagnosis of human African trypanosomiasisReducing Human-Tsetse Contact Significantly Enhances the Efficacy of Sleeping Sickness Active Screening Campaigns: A Promising Result in the Context of Elimination.Parasitological, serological and molecular survey of Trypanosoma evansi infection in dromedary camels from Cholistan Desert, PakistanHuman host determinants influencing the outcome of Trypanosoma brucei gambiense infections.Evaluating long-term effectiveness of sleeping sickness control measures in Guinea.[Human African trypanosomiasis in Côte d'Ivoire and Burkina Faso: optimization of epidemiologic surveillance strategies].Proteomics: a new way to improve human African trypanosomiasis diagnosis?Trypanosoma brucei gambiense Spliced Leader RNA Is a More Specific Marker for Cure of Human African Trypanosomiasis Than T. b. gambiense DNA.A LiTat 1.5 variant surface glycoprotein-derived peptide with diagnostic potential for Trypanosoma brucei gambiense.Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis.Prevention and control of malaria and sleeping sickness in Africa: where are we and where are we going?A polymorphism in the haptoglobin, haptoglobin related protein locus is associated with risk of human sleeping sickness within Cameroonian populations.Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Côte d'Ivoire.The study of trypanosome species circulating in domestic animals in two human African trypanosomiasis foci of Côte d'Ivoire identifies pigs and cattle as potential reservoirs of Trypanosoma brucei gambiense.Serological tests for gambiense human African trypanosomiasis detect antibodies in cattle.New insights in staging and chemotherapy of African trypanosomiasis and possible contribution of medicinal plants.Description of the first sleeping sickness case diagnosed in Burkina Faso since two decadesIntegrating innovations: a qualitative analysis of referral non-completion among rapid diagnostic test-positive patients in Uganda's human African trypanosomiasis elimination programme
P2860
Q27026504-A2345984-5DD8-4B74-A9FB-DAD0A1C4836DQ27926217-90DF0C73-5BD8-4CC1-909D-B96D1E0FE3C0Q28555206-6606832C-7E0E-4A9B-A04E-6958EC68951EQ33748367-A1118076-22E2-44D6-BBA4-25E4F7104DAAQ33751576-1893C7B2-5463-4842-8C63-26B42710C25BQ33866223-D93D2EDD-30C5-48CD-8502-5E1331D72BCAQ33866444-98B3447A-3ACA-47CC-BFA3-BE8EC2C7474EQ34312405-0EBBB20A-59D6-44C5-998C-5650EBE8A560Q34312428-709B35EA-D851-4A5D-8A34-9A0C3C10BB46Q34466454-DBB3C2D0-6BCD-474A-ACB1-793ED45ECE54Q34500882-28CB6321-1CAA-48DF-92B5-807C84E44CEFQ34526240-CF99D9C6-4DCD-40CF-B6BB-5587571F361EQ34623712-A06587CE-713E-4662-BAF8-731149DC1E67Q34796896-985F9BEA-F501-42A9-9E54-841EBCB5DC78Q35039193-9DB44D16-3871-4951-8CA9-2A9E3B199A76Q35208326-C5DDC54B-A8E6-41D9-AB89-5C1F7A80F94AQ35744063-F5AE250B-19C3-4CD7-AD99-9C22DDB078B4Q35939320-E5ABCAA3-5961-4FDB-9953-E21CED86734AQ36189949-A6D8D333-8FC4-475B-886A-913572873501Q36201259-68997730-9068-4844-9C51-8CE61285734DQ37034565-120DAA51-4F47-4A6D-BE11-635187300E04Q38115332-2C3AC62D-6056-4EBF-BD52-87B494D8422BQ39093411-D203C0A7-B30C-48C2-B3AD-241CD4FFE9E0Q39551459-89DE7AEA-41CD-461D-9D19-9672326BEC17Q40595918-1CACF3DF-7845-4A2D-95C4-BEDA3275DB87Q42704737-7894C333-E530-4900-AD43-B1A2ED617EB2Q43923950-78A2E6BB-73B9-41F7-9667-06E11A28913BQ43923961-75D66178-F087-4E5C-A892-17082E826474Q43923974-71D51446-1DC3-479D-9F6B-29D498E0BD23Q46924370-5E3F53CB-07D7-47FF-B0B1-9753E643AF5DQ53906272-BD79E8AA-65CC-48F8-AC6A-EA7FE0336105Q56334721-21194339-D31B-49BC-92A2-B4C219A6038BQ56888277-0E21CFAC-8019-4DBA-913E-4A7570FD6518
P2860
Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Revisiting the immune trypanol ...... eping sickness in West Africa.
@ast
Revisiting the immune trypanol ...... eping sickness in West Africa.
@en
type
label
Revisiting the immune trypanol ...... eping sickness in West Africa.
@ast
Revisiting the immune trypanol ...... eping sickness in West Africa.
@en
prefLabel
Revisiting the immune trypanol ...... eping sickness in West Africa.
@ast
Revisiting the immune trypanol ...... eping sickness in West Africa.
@en
P2093
P2860
P50
P1476
Revisiting the immune trypanol ...... eping sickness in West Africa.
@en
P2093
Bruno Bucheton
Dramane Kaba
Fabrice Courtin
Hamidou Ilboudo
Jacques Kaboré
Kouakou Lingue
Mamadou Camara
Oumou Camara
Roger Kambire
Rudy Baelmans
P2860
P356
10.1371/JOURNAL.PNTD.0000917
P407
P577
2010-12-21T00:00:00Z